Showing results (131-140 of 494) with videos related to

Sort By:
Pageof 50
European Journal of Cancer (Oxford, England : 1990)|July 2, 2022
What causes the death of patients with cutaneous squamous cell carcinoma? A prospective analysis in 1400 patientsThomas K Eigentler, Klaus Dietz, Ulrike Leiter, et al.
Cancer Immunology, Immunotherapy : CII|September 16, 2018
Accurate quantification of T-cells expressing PD-1 in patients on anti-PD-1 immunotherapyHenning Zelba, Jonas Bochem, Graham Pawelec, et al.
Biology Open|May 3, 2018
Embryonic bone morphogenetic protein and nodal induce invasion in melanocytes and melanoma cellsTobias Sinnberg, Heike Niessner, Mitchell P Levesque, et al.
Journal of the American Academy of Dermatology|February 5, 2005
Imiquimod in the treatment of extensive recurrent lentigo malignaAnne Kamin, Thomas K Eigentler, Peter Radny, et al.
Cancer Medicine|March 24, 2025
Distress and Its Determinants in 820 Consecutive Melanoma PatientsMarkus Reitmajer, Petra Riedel, Claus Garbe, et al.
Journal of Cancer Research and Clinical Oncology|November 24, 2016
Improvement of overall survival in stage IV melanoma patients during 2011-2014: analysis of real-world data in 441 patients of the German Central Malignant Melanoma Registry (CMMR)Andrea Forschner, Felizitas Eichner, Teresa Amaral, et al.
Oncoimmunology|June 23, 2015
The prognostic impact of specific CD4 T-cell responses is critically dependent on the target antigen in melanomaHenning Zelba, Benjamin Weide, Alexander Martens, et al.
Melanoma Research|September 8, 2011
Mucosal melanomas of the head and neck: new aspects of the clinical outcome, molecular pathology, and treatment with c-kit inhibitorsGiorgios Papaspyrou, Claus Garbe, Dirk Schadendorf, et al.
Cancer Letters|February 23, 2005
Numerical abnormalities of the Cyclin D1 gene locus on chromosome 11q13 in non-melanoma skin cancerJochen Utikal, Martin Udart, Ulrike Leiter, et al.
Pageof 50